Responses
Poster exhibition Day 2
P194 Epivin: a phase II double-blind randomised control trial investigating the use of epigallocatechin-3-gallate (veregen®, catephen®) vs placebo in the treatment of usual-typed vulval intraepithelial neoplasia
Compose a Response to This Article
Other responses
No responses have been published for this article.